Carregant...

Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation

OBJECTIVES: Despite advances in screening and prevention, rates of premature coronary artery disease (CAD) have been stagnant. The goals of this study were to investigate the barriers to early risk detection and preventive treatment in patients with premature CAD. In particular, we: 1) assessed the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Prev Cardiol
Autors principals: Vikulova, Diana N., Skorniakov, Ilia S., Bitoiu, Brendon, Brown, Chad, Theberge, Emilie, Fordyce, Christopher B., Francis, Gordon A., Humphries, Karin H., Mancini, G.B. John, Pimstone, Simon N., Brunham, Liam R.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8315606/
https://ncbi.nlm.nih.gov/pubmed/34327459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpc.2020.100036
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!